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ABSTRACT 
Graphene-based materials are the focus of intense research efforts to devise novel theranostic 
strategies for targeting the central nervous system. In this work, we have investigated the 
consequences of long-term exposure of primary rat astrocytes to pristine graphene (GR) and 
graphene oxide (GO) flakes. We demonstrate that GR/GO interfere with a variety of 
intracellular processes as a result of their internalization through the endo-lysosomal 
pathway. Graphene-exposed astrocytes acquire a more differentiated morphological 
phenotype associated with extensive cytoskeletal rearrangements. Profound functional 
alterations are induced by GO internalization, including the upregulation of inward-rectifying 
K+ channels and of Na+-dependent glutamate uptake, which are linked to the astrocyte 
capacity to control the extracellular homeostasis. Interestingly, GO-pretreated astrocytes 
promote the functional maturation of co-cultured primary neurons by inducing an increase in 
intrinsic excitability and in the density of GABAergic synapses. The results indicate that 
graphene nanomaterials profoundly affect astrocyte physiology in vitro, with consequences 
for neuronal network activity. This work supports the view that GO-based materials could be 
of great interest to address pathologies of the central nervous system associated to astrocyte 
dysfunctions.  
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There is a growing interest on the potential use of graphene (G)-based nanomaterials for 
biomedical applications directed to the central nervous system (CNS). To meet this 
challenge, thorough investigations on the safety and biocompatibility of G nanostructures in 
contact with the diverse brain cell types are required. This issue is extremely relevant for G 
materials, since their concentration, lateral dimension, charge and surface structure are 
known to influence their bio-interactions and need to be investigated in detail.1, 2 G-based 
scaffolds were shown to support the survival, growth and differentiation of primary neurons, 
thus representing safe and promising tools to promote neural growth and regeneration in 
vivo.3-6 However, recent studies reported that acute and chronic exposure of primary 
hippocampal and cortical neurons to graphene oxide (GO) caused altered Ca2+ dynamics and 
an excitatory/inhibitory imbalance in favor of inhibitory synaptic transmission.7, 8 
Astrocytes, which are the most numerous cell population in the mammalian CNS, are 
involved in the structural and functional regulation of neuronal circuits and contribute to 
maintain the homeostasis of the perineuronal milieu through the expression of specific ion 
channels and transporters.9 Astrocytes respond to pathological insults in vivo by changing 
some of their molecular and functional features, a process called ‘reactive astrocytosis’,10 
which can be beneficial or detrimental to the integrity and functionality of neuronal circuits 
depending on the specific pathological setting.11 The paramount importance of astrocytes in 
CNS physiology prompted us to address the impact of GR/GO exposure on this cell type, 
with the aim of providing further information on the biocompatibility profile of these 
nanomaterials when applied to the CNS and on their potential applications to treat astrocyte-
related pathologies.  
Very limited data on the impact of G-based nanomaterials on astrocytes are presently 
available. G-films were able to accelerate the maturation of neural stem cells and their 
progenies, including glial cells, by affecting their active and passive bioelectric membrane 
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properties.12 Moreover, GO nanosheets did not alter astrocyte viability in vitro, but affected 
their ability to release synaptic-like microvesicles involved in neuron-astrocyte 
communication.7 PEGylated rGO caused morphological changes and ROS production, and 
affected astrocyte viability in vitro and in vivo.13 Although these studies highlighted specific 
aspects of the interaction between G materials and astrocytes, no information is available to 
date on the molecular, cellular and functional consequences of exposing astrocytes to G 
nanomaterials. 
In this work, we carried out a detailed investigation of the effects of GR/GO exposure 
on the functional properties of primary rat cortical astrocytes. Although GR and GO did not 
affect cell viability, they promoted a marked change in cell shape from an epithelioid 
morphology to an asymmetrical shape with elongated processes, which was associated with 
extensive cytoskeletal rearrangements. Exposure to GO, but not to GR, caused the 
upregulation of K+ channels involved in extracellular K+ homeostasis and an increase in 
glutamate clearance that were causally related to GO internalization. Interestingly, GO-
treated astrocytes affected the functional properties of co-cultured neurons, by potentiating 
inhibitory synaptic transmission and accelerating the maturation of intrinsic neuronal 
excitability. These results indicate that GO profoundly affects astrocyte physiology in vitro, 
with repercussions on neuronal network activity. This work highlights the intrinsic different 
biological effects elicited by different nanomaterials and supports the relevance of GO for 
future applications in CNS pathologies associated to astrocyte dysfunctions. 
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RESULTS AND DISCUSSION 
 
GR and GO induce morphological changes without affecting astrocyte viability 
We characterized the physiological response of primary astrocytes to prolonged exposure to 
G-based materials, namely few-layer GR and GO. The former was prepared by exfoliation of 
graphite through interaction with melamine by ball-milling treatment, as described by Leon 
et al.14 GO, provided by Grupo Antolin Ingeniería (Burgos, Spain), was obtained by 
oxidation of carbon fibers. A complete description of material preparation and physical-
chemical characterization is reported in our previous work.8 
We isolated primary astrocytes from neonatal rat brain cortices (Figure S1) and 
cultured them for up to 7 days in vitro. Twenty-four hours after plating, cultures were 
exposed to an aqueous dispersion of 10 µg/ml of either GR or GO for 24 h, 72 h and 7 days. 
The viability of G- and vehicle-treated cultures (Ctrl: 0.09 ppm melamine/H2O for GR or 
H2O for GO) was evaluated as a function of the exposure time using immunohistochemistry 
and flow cytometry of propidium iodide (PI) to detect apoptotic cells. Exposure to G 
materials was not harmful to primary astrocytes at any of the tested exposure times (Figure 
S2a,b), indicating that GR and GO do not affect astrocyte survival nor induce 
astrogliopathy.15 
We next evaluated whether exposure to GR/GO altered cell morphology. To this end, 
astrocytes were immunostained with antibodies to the intermediate filament glial fibrillary 
acidic protein (GFAP) or subjected to scanning electron microscopy (SEM). 
Immunofluorescence revealed that exposure to G-materials induced a clear shape change 
that, from the regular and flat shape typical of quiescent primary astrocytes, became irregular 
and characterized by multiple thin processes and elongated protrusions resembling the 
morphology of in vitro activated/mature glia.16, 17 We quantitatively analyzed this 
phenomenon from SEM images using the circularity index as a measure of the symmetry and 
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regularity of the cell shape. Upon exposure to either GR or GO, astrocytes are characterized 
by a markedly lower index, indicative of a more elongated and asymmetrical shape with 
respect to vehicle-treated cells (Figure 1a). 
To better investigate the physical interaction of GR and GO with astrocytes, 
transmission electron microscopy (TEM) was used. As shown in Figure 1b, both GR and 
GO flakes (black arrowheads) were present inside the cells as aggregates of various sizes and 
compactness, mainly localized within membrane-bound vesicles, likely belonging to the 
endo-lysosomal pathway. The non-homogenous flake dispersion in solution may explain the 
formation of aggregates, although we cannot exclude that these agglomerates are formed 
inside cells upon fusion of multiple vesicles into larger intracellular structures. 
To get more insights into the process of G internalization and identify the intracellular 
organelles containing the internalized flakes, we focused on the endo-lysosomal pathway, 
known to be the preferential destination of nanoparticles and nanomaterials.18-21 Astrocytes 
exposed to G-flakes for 24 h, 72 h and 7 days were labeled with antibodies to early-
endosomal (EEA1) and lysosomal (LAMP1) markers. Three-dimensional Z-stack images 
were acquired with the reflection light acquisition modality,8, 22 which allows the 
visualization of G-flakes also in confocal mode and the precise quantification of their uptake 
and intracellular location (Figure S2c,d). When the percentage of GR/GO flakes overlapping 
with the cell area was quantified, the vast majority of astrocytes were found to internalize 
GR/GO, with percentages of internalized flakes over total flakes already very high after 24 h 
of exposure (Figure 1c; GR 42 ± 2.2%; GO 35 ± 1.1%). The co-localization of intracellular 
G particles with EEA1 and LAMP1 revealed that GR/GO flakes were initially internalized by 
EEA1-positive early endosomes and underwent a time-dependent transition to LAMP1-
positive organelles in which they reached the highest value at 7 days (Figure 1d), in line with 
previous studies describing the intracellular trafficking of nanomaterials in living systems.19-
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21, 23 In addition, the expression and maturation of LC3, a marker of autophagosomal 
membranes, investigated by immunofluorescence and western blotting (Figure S3), showed a 
complete absence of LC3 activation (LC3 II/I transition) in both GR- and GO-treated 
astrocytes, in contrast with the strong autophagy reaction observed in primary neurons upon 
G-flakes exposure.8 
The observed morphological changes could be due to G-induced cytoskeletal 
rearrangements, and/or to signaling cascades initiated by the physical interaction of G flakes 
with the cytoskeleton, phenomena that have been reported in other cellular models.24, 25 
Differently from carbon nanotubes, which have direct effects on GFAP,26 G flakes, due to 
their size and shape, might be able to insert into the inter-strand gap of the actin tetramer and 
cause its dissociation into monomers, which could eventually lead to the disruption of actin 
filaments.24 To explore this issue, astrocytes exposed to either GR or GO for 72 h were 
stained with fluorescent phalloidin and anti-α-tubulin antibodies to visualize actin filaments 
and microtubules, respectively. Three-dimensional Z-stack confocal images were acquired 
by adopting the reflection light acquisition modality to concomitantly visualize G-flakes.8, 22 
While control cells showed well-organized actin and tubulin filament bundles, both GR- and 
GO-treated astrocytes displayed breakdown of actin fibers and rearrangement of α-tubulin 
that irregularly aggregated upon G exposure (Figure 1e). These data suggest that the 
observed morphological changes are linked to the disruption/reorganization of the astrocyte 
cytoskeleton in response to G-flakes internalization. 
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Figure 1. Interactions of GR and GO with primary astrocytes. (a) Astrocytes exposed to 
GR and GO for 72 h were examined by SEM and immunofluorescence with anti-GFAP antibodies 
(white) and Hoechst33342 (blue). Left: The morphology of cells exposed to GR and GO was severely 
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affected compared to untreated samples (Ctrl). Scale bar, 50 µm. Right: Circularity index calculated 
from SEM images for each experimental condition (n = 100 cells, from 3 independent cell 
preparations). (b) The cell uptake of GR and GO and the intracellular location of G-flakes were 
confirmed by TEM. Large flakes were found outside the cells in close proximity to the cell membrane 
(left). Large amounts of G-flakes (black arrowheads) were observed into intracellular vesicles, such as 
lysosomes (middle) and larger lipid vesicles (right). (c) Total internalization of GR and GO was 
quantified over time and expressed as percent uptake with respect to the total G. (d) The extent of co-
localization of GR (left) and GO (right) with EEA1 and LAMP1 positive organelles was analyzed 
using the JACOP plugin of the ImageJ software (50 cells from n = 3 coverslips per experimental 
condition, from 3 independent cell preparations). (e) Confocal images of astrocytes stained with 
phalloidin (green, upper panel) and anti-α-tubulin (red, lower panel) to visualize actin filaments and 
microtubules, respectively, and with Hoechst33342 (blue) for cell nuclei. Scale bars: 5 and 1 µm for 
low and high magnification, respectively. Data are shown as means ± sem. *p<0.05, **p<0.01, 
***p<0.001, one-way ANOVA/Bonferroni’s tests. 
 
Differential effects of GR and GO on astrocyte electrical membrane properties 
Given the observed morphological changes, we assessed whether G-flakes affected the 
electrical membrane properties of astrocytes by performing patch-clamp recordings of K+ 
currents before and after exposure to either GR or GO (1-10 µg/ml; 72 h). It is well known 
that primary astrocytes mainly express outward rectifying K+ channels, and that only upon 
functional differentiation they acquire a more physiological K+ current profile characterized 
by the expression of inward rectifier K+ (Kir) channels.27, 28 Astrocytes were voltage-clamped 
at a holding potential of - 60 mV and challenged with voltage ramps or step protocols. 
Typical current traces elicited by both protocols in astrocytes exposed to GR are shown in 
Figure 2a. Treatment with GR did not significantly affect the amplitude and slope of the 
ramp currents; the current density measured at 120 mV was not significantly different 
between GR-treated and vehicle-treated samples (25.1 ± 4.8 pA/pF for Ctrl, 29.4 ± 6.7 pA/pF 
for GR). Addition of barium (Ba2+, 100 µM), which predominantly blocks inwardly 
rectifying K+ channels,29 slightly inhibited (~ 20%) the current response at 120 mV to a 
similar extent in vehicle- and GR-treated astrocytes. To unveil the time-dependent kinetics of 
the elicited current, we applied a step protocol. Upon step depolarization, rapidly activating 
and non-inactivating outward currents typical of delayed rectifier K+ conductance were 
elicited at potentials > -20 mV. The voltage and kinetics of the currents were not significantly 
different in vehicle- and GR-treated cells and the analysis of the current-voltage relationships 
depicted a similar voltage-dependent profile between vehicle- and GR-treated astrocytes 
(Figure 2b). Compared to vehicle-treated astrocytes, GR exposure did not affect the resting 
membrane potential (-28.0 ± 6.0 mV for Ctrl, -35.1 ± 5.2 mV for GR), the input resistance 
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(686 ± 51 MΩ for Ctrl, 756 ± 133 MΩ for GR) or the specific conductance (0.037 ± 0.005 
nS/pF for Ctrl, 0.038 ± 0.005 nS/pF for GR) (Figure 2c). 
By contrast, GO-treated astrocytes displayed a marked increase in outward rectifying 
currents compared to vehicle-treated cells (Figure 2d). Analysis of current density values 
recorded at 120 mV indicated an almost three-fold increase in GO-treated cells (26.9 ± 5.4 
pA/pF for Ctrl, 67.1 ± 11.4 pA/pF for GO). Moreover, administration of Ba2+ produced a 
significantly larger (~ 40%) inhibition of the ramp current measured at 120 mV compared to 
vehicle-treated astrocytes. The time and voltage-dependent kinetics of the current evoked 
with the voltage stimulation protocol were similar under the two experimental conditions. 
The current-voltage relationship shows that the increase in current amplitude observed in 
GO-treated astrocytes started at negative potentials and became more pronounced at positive 
membrane potentials (Figure 2e). Furthermore, GO hyperpolarized the resting membrane 
potential (-30.9 ± 6.5 mV for Ctrl and -50 ± 8 mV for GO), induced a significant decrease in 
input resistance (706 ± 50 MΩ for Ctrl, 487 ± 67 MΩ for GO) and augmented the specific 
conductance (0.03 ± 0.003 nS/pF for Ctrl, 0.06 ± 0.01 nS/pF for GO) (Figure 2f). 
Interestingly, a ten-fold lower dose of GO (1 µg/ml) elicited similar changes in specific 
conductance and current density, with a trend toward hyperpolarization and input resistance 
increase, revealing that the GO modulation is specific and dose-dependent (Figure S4). 
These data suggest that Ba2+-sensitive, weakly inward-rectifying Kir channels, which are 
typically upregulated in differentiated cultured astrocytes 28, 30 and downregulated in several 
glial-related pathologies,31 are likely responsible for mediating the increase in current 
amplitudes and the variations in the passive membrane properties of astrocytes in response to 
GO exposure. These findings extend previous reports in which other carbon-based materials, 
namely single-wall (SWCNTs) and multi-wall (MWCNTs) carbon nanotubes, have been 
shown to interact with K+ channels and alter their physiological functions.32-34  
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Figure. 2. Exposure to GO, but not GR, altered specific electrophysiological properties of 
astrocytes. (a) Whole-cell patch-clamp recordings of primary astrocytes exposed to GR. Left: 
Representative current traces elicited with a voltage ramp protocol in astrocytes treated for 72 h with 
either GR (10 µg/ml) or vehicle before (black traces) or after the addition of Ba2+ (100 µM, red traces) 
to the recording medium. Right: Representative traces of whole-cell currents evoked with a family of 
voltage steps. (b) GR exposure does not affect outward currents in astrocytes. Left: Current density 
values at 120 mV (n = 19 cells per experimental condition). Middle: Percentage of current inhibition 
at 120 mV in the presence of Ba2+ (n = 10 cells per experimental condition). Right: Current-voltage 
relationships in astrocytes exposed to GR (red) or vehicle (black) (n = 12 cells per experimental 
condition). (c) Passive membrane properties of astrocytes treated for 72 h with either GR (10 µg/ml) 
or vehicle. The resting membrane potential (mV; left), input resistance (MΩ; middle) and specific 
conductance (nS/pF; right) were unchanged (n = 19 cells per experimental condition). (d) Whole-cell 
patch-clamp recordings of primary astrocytes exposed to GO. Left: Representative current traces 
elicited with a voltage ramp protocol in astrocytes treated for 72 h with either GO (10 µg/ml) or 
vehicle before (black traces) or after exposure to Ba2+ (100 µM, red traces) to the recording medium. 
Right: Representative traces of whole-cell currents evoked with a family of voltage steps. (e) GO 
exposure markedly increases outward K+ conductance in astrocytes. Left: Current density values at 
120 mV (n = 19 cells per experimental condition). Middle: Percentage of current inhibition at 120 mV 
after application of 100 µM Ba2+ (n = 10 cells per experimental condition). Right: Current-voltage 
relationships in astrocytes exposed to GO (blue) or vehicle (black) (n = 12 cells from per experimental 
conditions). (f) GO exposure for 72 h affects the passive membrane properties of astrocytes. Resting 
membrane potential (mV; left), mean input resistance (MΩ; middle) and specific conductance (nS/pF; 
right) are shown (n = 19 cells per experimental condition). All data are collected from 3 independent 
cell preparations and are expressed as mean ± sem. *p<0.05, ***p<0.001, two-tailed Student's t-test/ 
Mann-Whitney U-test. 
 
The effects of GO on astrocyte membrane properties depend on the increased expression of 
Kir4.1 channels 
We next investigated whether the expression of Kir4.1 channels, the main component of the 
astroglial Kir current involved in K+ buffering,10 was affected by G exposure. Primary 
astrocytes treated with either GR or GO were stained with anti-Kir4.1 antibodies by avoiding 
the permeabilization step in the immunostaining procedure, which allowed monitoring the 
expression of Kir4.1 channels at the plasma membrane. Membrane labeling of Kir4.1 was 
higher and more diffuse in GO-treated astrocytes, whereas in GR-treated cells it was 
indistinguishable from control astrocytes (Figure 3a). To confirm the immunofluorescence 
results, G-treated and control astrocytes were subjected to western blotting. The total cell 
expression of Kir4.1 was also selectively increased upon exposure to GO, with a significant 
upregulation of both the monomeric and tetrameric forms of the channel (Figure 3b), which 
were instead not altered by GR (Figure S5). These data confirm that the changes in current 
amplitudes and passive membrane properties observed in GO-treated astrocytes can be 
attributed to the enhanced expression of Kir4.1 channels. 
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Kir4.1 channels control extracellular homeostasis also through the regulation of 
glutamate dynamics. In rodents, the expression of Kir4.1 has been linked to a positive 
modulation of glutamate clearance by astrocytes mediated by Na+-dependent uptake through 
glutamate transporters.35, 36 To address the possibility that the increase in Kir4.1 current could 
in turn increase glutamate clearance, we evaluated 3H-labeled glutamate (3H-Glu) uptake in 
primary astrocytes (Figure 3c). The cells were exposed to GR or GO for 72 h and then 
challenged with 3H-Glu in the presence or absence of choline in the extracellular bath, to 
isolate the Na+-dependent glutamate transport or following administration of Ba2+ to inhibit 
Kir4.1 channels. As expected, while GR did not promote any change in glutamate clearance 
compared to control, GO-treated astrocytes showed a marked increase in the uptake of 
extracellular glutamate. Importantly, replacement of Na+ with choline or Ba2+ decreased 
glutamate uptake similarly to what observed upon treatment with the competitive blocker of 
glutamate transporters dl-threo-β-benzyloxyaspartic acid (DL-TBOA; 100 µM),37 indicating 
the strong contribution of Kir4.1 activity to the Na+-dependent uptake of glutamate (Figure 
3c).  
We next explored whether the increase in glutamate uptake was associated with the 
enhanced expression of the two specific astroglial transporters GLT-1 and GLAST.38 
Immunofluorescence analysis of membrane-targeted transporters revealed a selective 
upregulation of GLT-1 membrane expression in GO-treated astrocytes (Figure 3d) compared 
to GR- or vehicle-treated astrocytes, while the membrane-targeted pool of GLAST 
transporters was not affected (Figure 3f). Western blotting experiments confirmed that total 
GLT-1 and GLAST expression was comparable under all the experimental conditions 
(Figure 3e,g). These data support the view that the long-term challenge of primary astrocytes 
with GO boosts their homeostatic capacity to control the dynamics of extracellular K+ and 
glutamate. 
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Figure 3. Kir4.1 expression and glutamate uptake are enhanced in astrocytes exposed to GO. (a) 
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Kir4.1 cell surface expression. Left: Representative images of primary astrocytes exposed to either 
GR or GO (10 µg/ml) for 72 h and stained with anti-Kir4.1 antibody (white) and Hoechst33342 
(blue). Scale bar, 20 µm. Right: Quantitative analysis of Kir4.1 immunoreactivity (n = 40 cells from n 
= 2 coverslips per experimental condition from 2 independent cell preparations). (b) Kir4.1 total 
expression. Left: A representative western blot experiment is shown, in which the tetrameric and 
monomeric forms of Kir4.1 are electrophoretically resolved. Right: Quantitative analysis of the 
immunoblots shows the overexpression of both the tetrameric and monomeric forms of Kir4.1 (n = 3 
from 3 independent cell preparations). (c) Glutamate uptake is enhanced in GO-treated astrocytes. 
Left: Quantitative analysis of glutamate uptake by astrocytes was analyzed after 72 h of exposure to 
either GR or GO (10 µg/ml). Data were normalized to the mean value of untreated astrocytes (n = 3 
independent preparations). Right: Schematics of the glutamate uptake assay showing the site of action 
of the inhibitors used. (d) GLT-1 cell surface expression. Representative images (upper panel) and 
quantitative analysis (lower panel) of GLT-1 immunoreactivity (green) showing an increase surface 
expression of the transporter upon GO exposure (n = 30 cells, from 2 independent cell preparations). 
Scale bar, 20 µm. (e) GLT-1 total expression. Representative western blot of total GLT-1 (upper 
panel) and quantitative analysis (lower panel), showing no changes in the total levels of GLT-1 upon 
GR or GO exposure. (f) GLAST cell surface expression. Representative images (upper panel) and 
quantification (lower panel) of GLAST immunoreactivity (red) (n = 30 cells, from 2 independent cell 
preparations). Scale bar, 20 µm. (g) GLAST total expression. Representative western blot of total 
GLAST and quantitative analysis (lower panels). No changes are observed in both cell surface and 
total expression of GLAST upon GR or GO exposure (n = 3 from 3 independent cell preparations). In 
quantitative western blot experiments Gadph was used as loading control. Data are expressed as mean 
± sem. *p<0.05, **p<0.01, ***p<0.001, One-way ANOVA/Bonferroni’s tests. 
 
GO internalization is responsible for shape change, Kir4.1 channel and GLT-1 transporter 
upregulation  
The effects of GR/GO on the shape and electrical properties of primary astrocytes could be in 
principle attributable to the membrane shear stress induced by macro-flakes adhering to the 
external surface of the cell or to the active internalization of nanosheets. In order to discern 
between these two possibilities and find a mechanistic explanation for the observed effects, 
we examined the effects of G exposure under conditions in which G internalization was 
prevented. Primary astrocytes were exposed to either GR or GO for 72 h in the presence or 
absence of low doses of sodium azide (NaN3; 1 µg/ml), a non-specific blocker of ATP-
dependent endocytosis.39 Astrocytes were then either processed for immunofluorescence 
analysis (Figure 4a-e) or subjected to western blotting for Kir4.1 (Figure 4f and Figure S5). 
While the NaN3 treatment per se did not alter the cell shape or the viability with respect to 
vehicle-treated astrocytes, it virtually abolished the marked changes in shape and circularity 
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index induced by either GR or GO (Figure 4b,d), likely due to the reduced flake 
internalization (Figure 4c,e). Additionally, NaN3 restored the physiological expression levels 
of Kir4.1 (Figure 4f) and membrane-targeted GLT-1 (Figure 4g). As a non-specific blocker 
of ATP-dependent endocytosis, NaN3 might affect the membrane recycling of receptors and 
transporters independently of the presence of G flakes. We could however exclude any non-
specific effect of NaN3 at the concentration and exposure time used in our experiments, as the 
expression of Kir4.1 and GLT-1 upon NaN3 treatment was comparable to that of non-treated 
samples (Figure 4f,g).  
Furthermore, treatment with NaN3 reverted the GO-induced increase of K+ currents 
and resting membrane potential, which recovered to the levels of control cells (Figure 4h-j). 
No changes were noticed in Kir4.1 expression upon GR exposure, with or without NaN3 
pretreatment (Figure S5). Collectively, these data directly link GO internalization to the 
observed changes in astrocyte shape and plasma membrane K+ conductance, suggesting that 
the uptake of the material is needed for triggering the observed effects. 
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Figure 4. Blockade of endocytosis by NaN3 rescues astrocyte shape changes and Kir4.1 and 
GLT-1 increases induced by GO. Astrocytes were exposed to either GR or GO (10 µg/ml) for 72 h 
in the presence or absence of 1 µg/ml NaN3. (a) Representative images of astrocytes stained for GFAP 
(green) and Hoechst33342 (blue). Scale bar, 50 µm. (b,d) The circularity index was calculated as a 
measure of the shape change of cells after GR (b) or GO (d) exposure. (c,e) The amount of 
internalization of GR (c) and GO (e) flakes was also quantified (n = 100 cells from n = 2 coverslips 
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per experimental condition, from 2 independent cell preparations). (f) Expression of Kir4.1 upon GO 
exposure in the presence or absence of NaN3. Left: A representative immunoblot is shown with the 
resolved tetrameric and monomeric species of Kir4.1. Gapdh was used as loading control. Right: 
Densitometric analysis of the immunoblots shows that the increased levels of both tetrameric and 
monomeric species of Kir4.1 are rescued upon NaN3 (n = 3 from 3 independent cell preparations). (g) 
Surface expression of GLT-1. Left: Representative images of astrocytes treated with GO (10 µg/ml) 
for 72 h in the presence or absence of NaN3 and surface stained for GLT-1 (red) and Hoechst33342 
(blue). Scale bar, 20 µm. Right: GLT-1 membrane expression was quantified (n = 100 cells from n = 
2 coverslips per experimental condition, from 2 independent cell preparations). (h-j) Whole-cell patch 
clamp recordings of primary astrocytes exposed to GO in the presence or absence of NaN3. (h) 
Representative current traces elicited with a voltage ramp protocol. (i,j) Values of current density at 
120 mV (i) and resting membrane potential (j) under the different experimental conditions (n ≥ 8 cells 
per experimental condition, from 3 independent cell preparations). Data are expressed as mean ± sem. 
Panels c,e: **p<0.01, two-tailed Student's t-test. All other panels: *p<0.05, **p<0.01, ***p<0.001, 
two-way ANOVA/Bonferroni’s tests. 
 
GO-exposed astrocytes alter inhibitory synaptic transmission and intrinsic excitability of 
co-cultured primary cortical neurons 
Potassium buffering and glutamate clearance are fundamental processes in astrocyte-to-
neuron communication. Since the above-reported results indicate that G-flakes alter astrocyte 
homeostatic function, we next investigated whether these changes could affect the in vitro 
development and maturation of primary neurons in astrocyte-neuron co-cultures.  
Astrocytes, which had been treated with either GR or GO for 72 h, were used as 
feeder substrate on top of which, following GR/GO removal, primary neurons in GR/GO-free 
medium were seeded and grown up to 10 DIV. Under these experimental conditions, GR or 
GO particles could only be observed in astrocytes and not in neurons (Figure S6). Primary 
cortical neurons were then analyzed at 10 DIV for miniature excitatory (mEPSCs) and 
inhibitory (mIPSCs) postsynaptic currents and intrinsic excitability. We found that frequency, 
amplitude, charge and current rise/decay times of mEPSCs did not significantly differ from 
control co-cultures (Figure 5a-c and Figure S7). These results were supported by 
immunostaining co-cultures with antibodies to the vesicular glutamate transporter VGLUT1, 
which revealed no difference in the density of excitatory synaptic contacts (Figure 5d and 
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Figure S8). In contrast, a significant increase in mIPSCs frequency was observed in neural 
networks grown onto GO-treated astrocytes in comparison with GR-treated and control 
astrocytes, in the absence of changes in the amplitude, charge and current rise/decay times 
(Figure 5e-g and Figure S7). To ascertain whether the changes in mIPSCs frequency were 
due to a concomitant change in the density of inhibitory synapses, we performed 
immunostaining with antibodies to the vesicular GABA transporter VGAT that revealed a 
significantly higher density of inhibitory synaptic contacts in neuronal networks co-cultured 
with GO-pretreated astrocytes with respect to GR-pretreated or control astrocytes (Figure 5h 
and Figure S8). Altogether, these observations indicate that exposure to GO enhances the 
ability of astrocytes to promote the formation and maturation of GABAergic synapses, with 
no effects on glutamatergic synapses. 
Next, we analyzed the intrinsic excitability of co-cultured neurons, a measure of the 
maturation of voltage-dependent conductance in developing networks. Electrophysiological 
measurements were performed in current-clamp configuration by injecting 500 ms current 
pulses with increments of 10 pA, and measuring the resulting action potential firing rate. The 
analysis of firing rate versus injected current revealed that neurons grown on GO-treated 
astrocytes had a significantly enhanced average and instantaneous firing rates evoked by 
depolarizing current pulses (Figure 5i). 
To better analyze the shape of the action potentials, we generated phase-plot graphs 
by plotting the first derivative of the membrane potential over time (dV/dt) versus the 
membrane potential. The first component of the phase plot is due to the spike initiation in the 
axon initial segment (AIS) and to its fast antidromic propagation to the soma that generates a 
sudden voltage increase from baseline called ‘kink’.40 The invasion of the soma by the AIS 
spike generates a delayed activation of somatodendritic Na+ channels that leads to the second 
phase-plot component, the somatodendritic spike. Interestingly, phase-plots revealed a more 
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prominent ‘kink’ in neurons co-cultured with GO-treated astrocytes. To quantify this effect, a 
linear regression fit of the first 10 experimental points that follow the threshold, set at 5 
mV/ms, was performed.40 This analysis showed that the phase-slope was significantly 
increased in neurons in contact with GO-treated astrocytes (Figure 5j).  
These results suggest that GO-treated astrocytes induce an acceleration of the 
maturation of the intrinsic excitability of cortical neurons by affecting voltage-gated channels 
not only in the cell soma, but also at the AIS. Although the precise mechanism(s) underlying 
the observed effects are still not defined, we can envisage at least two possible scenarios, 
which are not mutually exclusive. On one side, GO could induce long-lasting effects on 
astrocytes, which would continuously affect neurons up to DIV10 of co-culture. On the other 
side, GO exposure could affect astrocytes only transiently, in an early time window 
corresponding to the critical stages of neuronal differentiation and process outgrowth. This 
early-stage interaction could equally impact on network maturation and synapse formation, 
leading to the altered electrical properties observed at later stages in the mature network. 
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Figure 5. GO-primed astrocytes affect spontaneous excitatory synaptic currents and intrinsic 
excitability of co-cultured primary neurons. (a-d) Excitatory transmission. Representative 
recordings (a), cumulative distribution of interevent intervals and frequency (b), cumulative 
distribution of amplitude and mean amplitude (c) of mEPSCs (n = 10 cells from Ctrl, n = 10 cells for 
GR, n = 15 cells for GO) and density of VGLUT1-positive excitatory synapses (d; n = 30 cells per 
experimental condition). (e-h) Inhibitory transmission. Representative recordings (e), cumulative 
distribution of interevent intervals and frequency (f), cumulative distribution of amplitude and mean 
amplitude (g) of mIPSCs (n = 10 cells per experimental condition) and density of VGAT-positive 
inhibitory synapses (h; n = 30 cells per experimental condition). (i) Intrinsic excitability. Left: 
Representative traces of action potentials induced by the injection of 200 pA current steps for 500 ms 
for the three experimental conditions. Middle: Plot of the firing frequency versus injected current. 
Right: Instantaneous firing frequency (n = 21 cells for Ctrl, n = 15 cells for GR, n = 25 cells for GO). 
(j) Phase-plot analysis of action potentials. Left: Representative plots of the first derivative of the 
membrane voltage (dV/dt) versus membrane voltage (Vm) for each experimental condition. Right: 
Phase-slope measured at voltages more positive of 5 mV/ms (n = 21 cells for Ctrl, n = 15 cells for 
GR, n = 25 cells for GO). Data are collected from 3 independent cell preparations and expressed as 
mean ± sem. *p<0.05, **p<0.01, ***p<0.001, one-way ANOVA/Bonferroni’s tests. 
 
Astrocytes are fundamental for maintaining brain homeostasis and for the control of 
key neuronal processes such as synaptogenesis41, 42 and synaptic transmission.43, 44 There is 
also clear evidence that alterations of astrocyte capacity to buffer extracellular K+ and 
glutamate cause changes in neuronal network excitability, which could result in neurological 
disorders.31, 45, 46 In this study we performed a detailed functional analysis of the interaction 
between GR/GO and primary astroglial cells.  
The results show that GR/GO do not affect the viability of cultured astrocytes, which 
is in contrast with the effects caused by these materials in tumour cell lines.47 Astrocytes 
avidly internalize GR/GO flakes to a much higher extent than neurons8 and the endo-
lysosomal pathway results the preferential route of GR/GO intracellular trafficking. In 
contrast to what was previously observed in neurons,8 the high amount of internalized 
material does not induce any autophagy response, likely due to the better capacity of 
astrocytes to cope with external stressors.  
The morphological alterations elicited by GR/GO are triggered by ATP-dependent 
endocytosis of the flakes and by the subsequent rearrangement of microtubules and 
microfilaments. The latter finding is consistent with previous results showing that GO 
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nanosheets can insert into the inter-strand gap of actin tetramers, leading to structural 
alteration of actin filaments.24 At the functional level, the shape change following GR/GO 
exposure resembles that of astrocytes subjected to long-term treatment with a membrane-
permeable analogue of cyclic AMP (cAMP).16, 28, 48, 49 These astrocytes have long been 
considered as a model of reactive astrocytes49 even though recent work suggests that they 
may reflect a more mature phenotype.16  
 Notably, GO changes the passive membrane properties of astrocytes by upregulating 
the K+ conductance mediated by Kir4.1 channels, a molecular signature of mature astroglial 
cells in vivo.9 Kir4.1 channels preferentially localize at cell processes and perivascular 
endfeets and are responsible for the negative resting membrane potential of astrocytes.10 It 
has been shown that the expression of Kir4.1 and the associated membrane hyperpolarization 
are positively coupled to increased glutamate uptake.38 Consistently, GO-treated astrocytes 
display enhanced Na+-dependent glutamate uptake contributed by both Kir4.1 and GLT-1 
upregulation. All these observations support the view that the morphological and functional 
alterations induced by GO are reminiscent of a more mature phenotype. 
 Astrocytes shape neuronal activity by modulating neuronal maturation and synaptic 
transmission.50 Neurons co-cultured with GO-primed astrocytes display accelerated 
maturation of intrinsic excitability and increased inhibitory tone. It is tempting to speculate 
that GO-treated astrocytes promote the functional maturation of neurons by increasing the 
expression of voltage-gated ion channels and the formation and functional maturation of 
GABAergic synapses, an effect previously reported to be mediated by astrocyte-secreted 
neurotrophins.51 
 Other studies have described that astrocytes actively interact with different 
nanomaterials. Mouse cortical astrocytes grown on single-walled carbon nanotube films 
displayed increased proliferation and de-differentiated morphology, interpreted as a 
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nonreactive phenotype.26, 52 By contrast, the same material delivered as colloidal solution 
promoted the stellation of cultured astrocytes with increased GFAP immunoreactivity53 and 
glutamate uptake.54 Cortical astrocytes plated on synthetic polyamide nanofibers acquired a 
stellate morphology caused by activation of Rho GTPases55 and promoted neurite outgrowth 
when co-cultured with neurons, a result that was associated with the increased secretion of 
growth factors. The same substrate was also shown to reduce the reactive immunological 
response of cortical astrocytes differentiated by long-term treatment with cAMP.56  
Our study demonstrates that long-term exposure of primary astrocytes to GR/GO 
affects several aspects of their homeostatic capacity, with indirect influence on the functional 
plasticity of co-cultured neuronal cells. Interestingly, most of the effects are specific for GO, 
which is probably due to its surface charge and higher reactivity with cells. To date, GO is 
preferred for biomedical applications with respect to GR, because of its higher solubility, 
stability in biological fluids and the possibility of surface functionalization. Further studies in 
vivo will address the future potential applications of GO in CNS pathologies.   
 25 
Corresponding Author Information 
Corresponding authors: Mattia Bramini, Center for Synaptic Neuroscience and Technology, 
Istituto Italiano di Tecnologia (IIT), Largo Rosanna Benzi 10, 16132 Genova, Italy; 
mattia.bramini@iit.it; Stefano Ferroni, Department of Pharmacy and Biotechnology, 
University of Bologna, Via San Donato 19/2, 40127 Bologna, Italy; stefano.ferroni@unibo.it 
 
Author Contributions 
M.C. performed cell biology, electrophysiology experiments and analysis, M.B. performed 
cell biology, cell viability, electron and fluorescence microscopy, immunofluorescence 
experiments and analysis; A.A. and T.B. participated in designing and discussion of the 
work; A.R. performed western blotting; E.G. helped with immunofluorescence sample 
preparation and confocal acquisition; E.V. contributed to the synthesis and characterization of 
graphene material; M.B., F.C. and F.B. conceived the study; M.B., M.C., S.F., F.C. and F.B. 
conceived the experimental design and contributed to the analysis of the data; M.B., M.C., 
S.F., F.C. and F.B. wrote the manuscript. All authors have given approval to the final version 
of the manuscript. 
 
Notes 
The authors declare no competing financial interest. 
 
Funding Sources 
We acknowledge financial support from the European Union’s Horizon 2020 Research and 
Innovation Programme under Grant Agreement No. 696656 - Graphene Flagship - Core1 and 
Grant Agreement No. 785219 - Graphene Flagship - Core2. 
 
 26 
Acknowledgments 
The Electron Microscopy facility members of the Nanophysics department at the Fondazione 
Istituto Italiano di Tecnologia (IIT, Genova, Italy) are kindly acknowledged for use and 
assistance with electron imaging. A. Mehilli is gratefully acknowledged for primary cell 
culture preparations, as well as D. Moruzzo, F. Canu and I. Dallorto for technical and 
administrative support. The Antolin Group is also acknowledged for providing the 
commercial material.  
 
Supporting Information Available: Supplementary figures (S1-S8) and detailed 
experimental procedures (Materials and Methods). 
  
 27 
REFERENCES 
 
1. Singh, Z., Applications and toxicity of graphene family nanomaterials and their 
composites. Nanotechnology, science and applications 2016, 9, 15-28. 
2. Reina, G.; Gonzalez-Dominguez, J. M.; Criado, A.; Vazquez, E.; Bianco, A.; Prato, 
M., Promises, facts and challenges for graphene in biomedical applications. Chemical Society 
reviews 2017, 46 (15), 4400-4416. 
3. Fabbro, A.; Scaini, D.; Leon, V.; Vazquez, E.; Cellot, G.; Privitera, G.; Lombardi, L.; 
Torrisi, F.; Tomarchio, F.; Bonaccorso, F.; Bosi, S.; Ferrari, A. C.; Ballerini, L.; Prato, M., 
Graphene-Based Interfaces Do Not Alter Target Nerve Cells. ACS nano 2016, 10 (1), 615-23. 
4. Bendali, A.; Hess, L. H.; Seifert, M.; Forster, V.; Stephan, A. F.; Garrido, J. A.; 
Picaud, S., Purified neurons can survive on peptide-free graphene layers. Advanced 
healthcare materials 2013, 2 (7), 929-33. 
5. Sahni, D.; Jea, A.; Mata, J. A.; Marcano, D. C.; Sivaganesan, A.; Berlin, J. M.; Tatsui, 
C. E.; Sun, Z.; Luerssen, T. G.; Meng, S.; Kent, T. A.; Tour, J. M., Biocompatibility of 
pristine graphene for neuronal interface. J Neurosurg Pediatr 2013, 11 (5), 575-83. 
6. Pampaloni, N. P.; Lottner, M.; Giugliano, M.; Matruglio, A.; D'Amico, F.; Prato, M.; 
Garrido, J. A.; Ballerini, L.; Scaini, D., Single-layer graphene modulates neuronal 
communication and augments membrane ion currents. Nature nanotechnology 2018. 
7. Rauti, R.; Lozano, N.; Leon, V.; Scaini, D.; Musto, M.; Rago, I.; Ulloa Severino, F. 
P.; Fabbro, A.; Casalis, L.; Vazquez, E.; Kostarelos, K.; Prato, M.; Ballerini, L., Graphene 
Oxide Nanosheets Reshape Synaptic Function in Cultured Brain Networks. ACS nano 2016, 
10 (4), 4459-71. 
8. Bramini, M.; Sacchetti, S.; Armirotti, A.; Rocchi, A.; Vazquez, E.; Leon Castellanos, 
V.; Bandiera, T.; Cesca, F.; Benfenati, F., Graphene Oxide Nanosheets Disrupt Lipid 
Composition, Ca(2+) Homeostasis, and Synaptic Transmission in Primary Cortical Neurons. 
ACS nano 2016, 10 (7), 7154-71. 
9. Benfenati, V.; Ferroni, S., Water transport between CNS compartments: functional 
and molecular interactions between aquaporins and ion channels. Neuroscience 2010, 168 
(4), 926-40. 
10. Olsen, M. L.; Sontheimer, H., Functional implications for Kir4.1 channels in glial 
biology: from K+ buffering to cell differentiation. Journal of neurochemistry 2008, 107 (3), 
589-601. 
11. Burda, J. E.; Sofroniew, M. V., Reactive gliosis and the multicellular response to 
CNS damage and disease. Neuron 2014, 81 (2), 229-48. 
12. Guo, R.; Zhang, S.; Xiao, M.; Qian, F.; He, Z.; Li, D.; Zhang, X.; Li, H.; Yang, X.; 
Wang, M.; Chai, R.; Tang, M., Accelerating bioelectric functional development of neural 
stem cells by graphene coupling: Implications for neural interfacing with conductive 
materials. Biomaterials 2016, 106, 193-204. 
13. Mendonca, M. C.; Soares, E. S.; de Jesus, M. B.; Ceragioli, H. J.; Batista, A. G.; 
Nyul-Toth, A.; Molnar, J.; Wilhelm, I.; Marostica, M. R., Jr.; Krizbai, I.; da Cruz-Hofling, M. 
A., PEGylation of Reduced Graphene Oxide Induces Toxicity in Cells of the Blood-Brain 
Barrier: An in Vitro and in Vivo Study. Molecular pharmaceutics 2016, 13 (11), 3913-3924. 
14. Leon, V.; Rodriguez, A. M.; Prieto, P.; Prato, M.; Vazquez, E., Exfoliation of graphite 
with triazine derivatives under ball-milling conditions: preparation of few-layer graphene via 
selective noncovalent interactions. ACS nano 2014, 8 (1), 563-71. 
15. Takuma, K.; Baba, A.; Matsuda, T., Astrocyte apoptosis: implications for 
neuroprotection. Progress in neurobiology 2004, 72 (2), 111-27. 
16. Paco, S.; Hummel, M.; Pla, V.; Sumoy, L.; Aguado, F., Cyclic AMP signaling 
restricts activation and promotes maturation and antioxidant defenses in astrocytes. BMC 
genomics 2016, 17, 304. 
17. Sun, D.; Jakobs, T. C., Structural remodeling of astrocytes in the injured CNS. The 
Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry 2012, 18 
(6), 567-88. 
18. Shapero, K.; Fenaroli, F.; Lynch, I.; Cottell, D. C.; Salvati, A.; Dawson, K. A., Time 
and space resolved uptake study of silica nanoparticles by human cells. Molecular bioSystems 
2011, 7 (2), 371-8. 
 28 
19. Mu, Q.; Su, G.; Li, L.; Gilbertson, B. O.; Yu, L. H.; Zhang, Q.; Sun, Y. P.; Yan, B., 
Size-dependent cell uptake of protein-coated graphene oxide nanosheets. ACS applied 
materials & interfaces 2012, 4 (4), 2259-66. 
20. Sandin, P.; Fitzpatrick, L. W.; Simpson, J. C.; Dawson, K. A., High-speed imaging of 
Rab family small GTPases reveals rare events in nanoparticle trafficking in living cells. ACS 
nano 2012, 6 (2), 1513-21. 
21. Bramini, M.; Ye, D.; Hallerbach, A.; Nic Raghnaill, M.; Salvati, A.; Aberg, C.; 
Dawson, K. A., Imaging approach to mechanistic study of nanoparticle interactions with the 
blood-brain barrier. ACS nano 2014, 8 (5), 4304-12. 
22. Patskovsky, S.; Bergeron, E.; Rioux, D.; Meunier, M., Wide-field hyperspectral 3D 
imaging of functionalized gold nanoparticles targeting cancer cells by reflected light 
microscopy. Journal of biophotonics 2015, 8 (5), 401-7. 
23. Ye, D.; Raghnaill, M. N.; Bramini, M.; Mahon, E.; Aberg, C.; Salvati, A.; Dawson, K. 
A., Nanoparticle accumulation and transcytosis in brain endothelial cell layers. Nanoscale 
2013, 5 (22), 11153-65. 
24. Tian, X.; Yang, Z.; Duan, G.; Wu, A.; Gu, Z.; Zhang, L.; Chen, C.; Chai, Z.; Ge, C.; 
Zhou, R., Graphene Oxide Nanosheets Retard Cellular Migration via Disruption of Actin 
Cytoskeleton. Small 2017, 13 (3). 
25. Matesanz, M. C.; Vila, M.; Feito, M. J.; Linares, J.; Goncalves, G.; Vallet-Regi, M.; 
Marques, P. A.; Portoles, M. T., The effects of graphene oxide nanosheets localized on F-
actin filaments on cell-cycle alterations. Biomaterials 2013, 34 (5), 1562-9. 
26. Gottipati, M. K.; Bekyarova, E.; Brenner, M.; Haddon, R. C.; Parpura, V., Changes in 
the morphology and proliferation of astrocytes induced by two modalities of chemically 
functionalized single-walled carbon nanotubes are differentially mediated by glial fibrillary 
acidic protein. Nano letters 2014, 14 (7), 3720-7. 
27. MacFarlane, S. N.; Sontheimer, H., Electrophysiological changes that accompany 
reactive gliosis in vitro. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 1997, 17 (19), 7316-29. 
28. Ferroni, S.; Marchini, C.; Schubert, P.; Rapisarda, C., Two distinct inwardly 
rectifying conductances are expressed in long term dibutyryl-cyclic-AMP treated rat cultured 
cortical astrocytes. FEBS letters 1995, 367 (3), 319-25. 
29. Ransom, C. B.; Sontheimer, H., Biophysical and pharmacological characterization of 
inwardly rectifying K+ currents in rat spinal cord astrocytes. Journal of neurophysiology 
1995, 73 (1), 333-46. 
30. Benfenati, V.; Caprini, M.; Nobile, M.; Rapisarda, C.; Ferroni, S., Guanosine 
promotes the up-regulation of inward rectifier potassium current mediated by Kir4.1 in 
cultured rat cortical astrocytes. Journal of neurochemistry 2006, 98 (2), 430-45. 
31. Dossi, E.; Vasile, F.; Rouach, N., Human astrocytes in the diseased brain. Brain 
research bulletin 2018, 136, 139-156. 
32. Chen, T.; Yang, J.; Ren, G.; Yang, Z.; Zhang, T., Multi-walled carbon nanotube 
increases the excitability of hippocampal CA1 neurons through inhibition of potassium 
channels in rat's brain slices. Toxicology letters 2013, 217 (2), 121-8. 
33. Xu, H.; Bai, J.; Meng, J.; Hao, W.; Xu, H.; Cao, J. M., Multi-walled carbon nanotubes 
suppress potassium channel activities in PC12 cells. Nanotechnology 2009, 20 (28), 285102. 
34. Park, K. H.; Chhowalla, M.; Iqbal, Z.; Sesti, F., Single-walled carbon nanotubes are a 
new class of ion channel blockers. The Journal of biological chemistry 2003, 278 (50), 
50212-6. 
35. Inyushin, M.; Kucheryavykh, L. Y.; Kucheryavykh, Y. V.; Nichols, C. G.; Buono, R. 
J.; Ferraro, T. N.; Skatchkov, S. N.; Eaton, M. J., Potassium channel activity and glutamate 
uptake are impaired in astrocytes of seizure-susceptible DBA/2 mice. Epilepsia 2010, 51 (9), 
1707-13. 
36. Kucheryavykh, Y. V.; Kucheryavykh, L. Y.; Nichols, C. G.; Maldonado, H. M.; 
Baksi, K.; Reichenbach, A.; Skatchkov, S. N.; Eaton, M. J., Downregulation of Kir4.1 inward 
rectifying potassium channel subunits by RNAi impairs potassium transfer and glutamate 
uptake by cultured cortical astrocytes. Glia 2007, 55 (3), 274-81. 
37. Shimamoto, K.; Lebrun, B.; Yasuda-Kamatani, Y.; Sakaitani, M.; Shigeri, Y.; 
Yumoto, N.; Nakajima, T., DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory 
amino acid transporters. Molecular pharmacology 1998, 53 (2), 195-201. 
 29 
38. Anderson, C. M.; Swanson, R. A., Astrocyte glutamate transport: review of 
properties, regulation, and physiological functions. Glia 2000, 32 (1), 1-14. 
39. Schmid, S. L.; Carter, L. L., ATP is required for receptor-mediated endocytosis in 
intact cells. The Journal of cell biology 1990, 111 (6 Pt 1), 2307-18. 
40. Naundorf, B.; Wolf, F.; Volgushev, M., Unique features of action potential initiation 
in cortical neurons. Nature 2006, 440 (7087), 1060-3. 
41. Pyka, M.; Wetzel, C.; Aguado, A.; Geissler, M.; Hatt, H.; Faissner, A., Chondroitin 
sulfate proteoglycans regulate astrocyte-dependent synaptogenesis and modulate synaptic 
activity in primary embryonic hippocampal neurons. The European journal of neuroscience 
2011, 33 (12), 2187-202. 
42. Kucukdereli, H.; Allen, N. J.; Lee, A. T.; Feng, A.; Ozlu, M. I.; Conatser, L. M.; 
Chakraborty, C.; Workman, G.; Weaver, M.; Sage, E. H.; Barres, B. A.; Eroglu, C., Control 
of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. 
Proceedings of the National Academy of Sciences of the United States of America 2011, 108 
(32), E440-9. 
43. Allen, N. J.; Bennett, M. L.; Foo, L. C.; Wang, G. X.; Chakraborty, C.; Smith, S. J.; 
Barres, B. A., Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via 
GluA1 AMPA receptors. Nature 2012, 486 (7403), 410-4. 
44. Albrecht, D.; Lopez-Murcia, F. J.; Perez-Gonzalez, A. P.; Lichtner, G.; Solsona, C.; 
Llobet, A., SPARC prevents maturation of cholinergic presynaptic terminals. Molecular and 
cellular neurosciences 2012, 49 (3), 364-74. 
45. David, Y.; Cacheaux, L. P.; Ivens, S.; Lapilover, E.; Heinemann, U.; Kaufer, D.; 
Friedman, A., Astrocytic dysfunction in epileptogenesis: consequence of altered potassium 
and glutamate homeostasis? The Journal of neuroscience : the official journal of the Society 
for Neuroscience 2009, 29 (34), 10588-99. 
46. Bellot-Saez, A.; Kekesi, O.; Morley, J. W.; Buskila, Y., Astrocytic modulation of 
neuronal excitability through K(+) spatial buffering. Neuroscience and biobehavioral reviews 
2017, 77, 87-97. 
47. Liu, W.; Sun, C.; Liao, C.; Cui, L.; Li, H.; Qu, G.; Yu, W.; Song, N.; Cui, Y.; Wang, 
Z.; Xie, W.; Chen, H.; Zhou, Q., Graphene Enhances Cellular Proliferation through 
Activating the Epidermal Growth Factor Receptor. Journal of agricultural and food 
chemistry 2016, 64 (29), 5909-18. 
48. Shapiro, D. L., Morphological and biochemical alterations in foetal rat brain cells 
cultured in the presence of monobutyryl cyclic AMP. Nature 1973, 241 (5386), 203-4. 
49. Wandosell, F.; Bovolenta, P.; Nieto-Sampedro, M., Differences between reactive 
astrocytes and cultured astrocytes treated with di-butyryl-cyclic AMP. Journal of 
neuropathology and experimental neurology 1993, 52 (3), 205-15. 
50. Araque, A.; Navarrete, M., Glial cells in neuronal network function. Philosophical 
transactions of the Royal Society of London. Series B, Biological sciences 2010, 365 (1551), 
2375-81. 
51. Elmariah, S. B.; Oh, E. J.; Hughes, E. G.; Balice-Gordon, R. J., Astrocytes regulate 
inhibitory synapse formation via Trk-mediated modulation of postsynaptic GABAA 
receptors. The Journal of neuroscience : the official journal of the Society for Neuroscience 
2005, 25 (14), 3638-50. 
52. Min, J. O.; Kim, S. Y.; Shin, U. S.; Yoon, B. E., Multi-walled carbon nanotubes 
change morpho-functional and GABA characteristics of mouse cortical astrocytes. Journal of 
nanobiotechnology 2015, 13, 92. 
53. Gottipati, M. K.; Kalinina, I.; Bekyarova, E.; Haddon, R. C.; Parpura, V., Chemically 
functionalized water-soluble single-walled carbon nanotubes modulate morpho-functional 
characteristics of astrocytes. Nano letters 2012, 12 (9), 4742-7. 
54. Gottipati, M. K.; Bekyarova, E.; Haddon, R. C.; Parpura, V., Chemically 
functionalized single-walled carbon nanotubes enhance the glutamate uptake characteristics 
of mouse cortical astrocytes. Amino acids 2015, 47 (7), 1379-88. 
55. Tiryaki, V. M.; Ayres, V. M.; Khan, A. A.; Ahmed, I.; Shreiber, D. I.; Meiners, S., 
Nanofibrillar scaffolds induce preferential activation of Rho GTPases in cerebral cortical 
astrocytes. International journal of nanomedicine 2012, 7, 3891-905. 
 30 
56. Tiryaki, V. M.; Ayres, V. M.; Ahmed, I.; Shreiber, D. I., Differentiation of reactive-
like astrocytes cultured on nanofibrillar and comparative culture surfaces. Nanomedicine 
2015, 10 (4), 529-45. 
 
SUPPLEMENTARY MATERIAL 
 
Graphene oxide upregulates the homeostatic functions 
of primary astrocytes and modulates astrocyte-to-neuron 
communication 
 
Martina Chiacchiaretta†§°, Mattia Bramini†°, Anna Rocchi†, Andrea Armirotti#, Emanuele Giordano†, 
Ester Vázquez‡, Tiziano Bandiera#, Stefano Ferroni§, Fabrizia Cesca†*ϕ and Fabio Benfenati†* ϕ 
 
†Center for Synaptic Neuroscience and Technology and Graphene Labs, Istituto Italiano di Tecnologia, 
16163 Genova, Italy; #Drug Discovery and Development and Graphene Labs, Istituto Italiano di 
Tecnologia, 16163 Genova, Italy; ‡Departamento de Química Orgánica, Universidad de Castilla La-
Mancha, 13071 Ciudad Real, Spain; §Department of Pharmacy and Biotechnology, University of 
Bologna, 40126 Bologna; *IRCCS Ospedale Policlinico San Martino, Genova, Italy. 
 
°Equal contribution 
ϕ Senior authors 
 
 
Corresponding authors:  
Mattia Bramini, PhD; e-mail: mattia.bramini@iit.it 
Stefano Ferroni, PhD; e-mail: stefano.ferroni@unibo.it  
  
 
 
Figure S1. Characterization of glial cell subpopulations. Left: Glial cell subpopulations were 
identified by immunofluorescence with anti-GFAP (glial fibrillary acidic protein; astrocytes), anti-Iba1 
(ionizing calcium-binding adaptor molecule 1; microglia) and anti-NG2 (neural/glia antigen 2; 
polydendrocytes) antibodies and counted 72 h after plating. Scale bars, 50 µm. Right: Percent 
composition of the various glial subpopulations (mean ± sem); n = 2000 cells from 3 independent cell 
preparations.  
  
	
Figure S2. GR and GO are internalized by astrocytes through the endo-lysosomal pathway. (a,b) 
Astrocytes were exposed to either GR (a) or GO (b). Cell viability was evaluated by flow cytometry 
analysis using propidium iodide (PI) staining. The percentages of PI-positive cells with respect to the 
total number of cells were calculated for each experimental group (45,000 cells from n = 3 per 
experimental condition, from 3 independent cell preparations). (c,d) Astrocytes were exposed to either 
GR (c) or GO (d) up to 7 days, as indicated. Astrocytes were stained with anti-EEA1 and anti-LAMP1 
antibodies for early endosome and lysosome identification, respectively, and Hoechst33342 for cell 
nuclei. Three-dimensional confocal images were acquired. Scale bars: low magnification xy images 
(top left of each panel): 20 µm main image and 5 µm xz and yz cross-section; high magnification xy 
images (top right of each panel): 3 µm main image and 2 µm xz and yz cross-section; single-channel 
boxes: 3 µm. 
  
 
 
Figure S3. Internalized GR and GO do not trigger autophagy. (a) Astrocytes were exposed to 
either GR or GO (10 µg/ml) for 72 h, stained with anti-LC3 and anti-GFAP antibodies, and imaged by 
confocal microscopy (scale bar, 20 µm). (b) Western blotting of LC3 and quantification of the LC3 II/I 
ratio. Gadph was used as a loading control (means ± sem; n = 3 independent cell preparations). 
  
 
Figure S4. GO affects the passive membrane properties of astrocytes in a dose-dependent 
fashion. (a) Representative traces of whole-cell currents evoked with voltage ramps (upper traces) or a 
voltage-step protocol (lower traces) in astrocytes treated for 72 h with vehicle, 1 or 10 µg/ml GO. (b) 
Table summarizing the electrophysiological parameters of astrocytes under the various experimental 
conditions. Means ± sem (n ≥ 10 for each treatment; from 3 independent cell preparations). *p<0.05, 
**p<0.01, one-way ANOVA/Bonferroni's tests. 
  
 Figure S5. Kir4.1 expression upon GR exposure and upon blockade of endocytosis. Astrocytes 
were exposed to GR (10 µg/ml) for 72 h in the presence or absence of 1 µg/ml of NaN3. (a) A 
representative immunoblot is shown with the resolved tetrameric and monomeric species of Kir4.1. 
Gapdh was used as loading control. (b) Densitometric analysis (means ± sem) shows no significant 
changes in both tetrameric and monomeric species of Kir4.1 in control and NaN3-treated samples (one-
way ANOVA/Bonferroni’s tests; n = 2 from 2 independent cell preparations). 
  
 Figure S6. G flakes are restricted to astrocytes in astrocyte-neuron co-cultures. Astrocytes that had 
been pretreated with vehicle (Ctrl), GR or GO (10 µg/ml) for 72 h and washed were used as feeder 
substrate to plate primary neurons. Neuronal development was then followed in GR/GO-free medium 
for 10 DIV. (a) Representative images of neurons stained for βIII tubulin (red) and astrocytes stained 
for GFAP (green) at DIV 10. Scale bars, 50 µm. (b) Left: Representative zoomed images show that GR 
and GO flakes (white) are predominantly in contact with astrocytes (scale bars: 20 µm for GR and 10 
µm for GO). Right: quantification of G flakes in contact with astrocytes and neurons, as quantified by 
reflectance confocal microscopy in double-labeled co-cultures at 10 DIV.	
  
 
Figure S7. Exposure to GR or GO does not affect the kinetics of mEPSCs and mIPSCs. (a,b) 
Representative recordings of mEPSCs (a) and examples of individual events over an enlarged 
timescale (b). (c) Mean ± sem of mEPSC charge (left), rise (middle) and decay (right) times (Ctrl, n = 
10 cells; GR, n = 10 cells; GO, n = 15 cells; from 3 independent cell preparations). (d,e) Representative 
recordings of mIPSCs (d) and examples of individual events over an enlarged time scale (e). (f) Mean 
± sem of mIPSC charge (left), rise (middle) and decay (right) times. No significant differences were 
observed (n = 10 cells per experimental condition from 3 independent cell preparations).  
  
 
 
Figure S8. GO exposure increases the density of inhibitory, but not of excitatory, synapses. (a-e) 
Representative images of neurons stained for βIII tubulin (gray), VGLUT1 (red) and VGAT (green). 
Nuclei were stained with Hoechst 33342 (blue). Scale bars: 5 µm in main images (a-c) and 2 µm in 
zoomed images (d,e). (f,g) Density of VGLUT1-positive excitatory synapses (f) and VGAT-positive 
inhibitory synapses (g) in neurons co-cultured with control astrocytes (Ctrl), or with astrocytes that had 
been exposed to either GR or GO for 72 h before neuron plating. Data are expressed as means ± sem. 
*p < 0.05, one-way ANOVA/Bonferroni’s tests (n = 30 cells per experimental condition, from 3 
independent co-culture preparations). 
  
METHODS 
Synthesis and characterization of pristine graphene and graphene oxide 
Pristine graphene (GR) flakes were prepared by exfoliation of graphite through interaction with 
melamine by ball-milling treatment.12 Graphene oxide (GO) was provided by Grupo Antolin Ingeniería 
(Burgos, Spain) by oxidation of carbon fibers (GANF Helical-Ribbon Carbon Nanofibres, GANF®) and 
sodium nitrate in sulfuric acid at 0 °C. Briefly, in GR preparation, melamine was removed by filtration 
to obtain stable dispersions of few-layer graphene. Elemental analysis found 0.09 ppm melamine in 
dispersions of 0.09 mg/ml GR; thus the same concentration of melamine was used as control for GR-
treated samples. The elemental analysis of GO gave the following results (percent weight): 47.71 ± 
0.03 wt % C, 3.04 ± 0.02 wt % H, 0.15 ± 0.01 wt % N, and 0.27 ± 0.03 wt % S. Oxygen content was 
therefore calculated at ca. 48% by weight. Dynamic light scattering (DLS) and transmission electron 
microscopy (TEM) analysis displayed a higher lateral size distribution of GR (widely spread from 500 
to 2000 nm) compared to GO (100 − 1500 nm, with main peak below 500 nm) flakes. Raman 
spectroscopy provided a further characterization of the two materials. Graphene exhibits G and 2D 
modes around 1573 and 2700 cm−1, which always satisfy the Raman selection rules, while the D peak 
around 1345 cm−1 required a defect for its activation. For a complete and detailed description of GR and 
GO material synthesis and physical-chemical characterization, please refer to (Leon et al., 2014)12 and 
(Bramini et al., 2016).7 
 
Preparation of primary astrocytes and astrocyte/neuron co-cultures 
All experiments were carried out in accordance with the guidelines established by the European 
Community Council (Directive 2010/63/EU of 22 September 2010) and were approved by the Italian 
Ministry of Health (Authorization #306/2016-PR on March 24, 2016). Primary cultures were prepared 
from wild-type Sprague-Dawley rats (Charles River, Calco, Italy). All efforts were made to minimize 
suffering and to reduce the number of animals used. Rats were sacrificed by CO2 inhalation, and 18-day 
embryos (E18) were removed immediately by cesarean section. Briefly, enzymatically dissociated 
astrocytes were plated on poly-D-lysine-coated (0.01 mg/ml) cell culture flasks and maintained in a 
humidified incubator with 5% CO2 for 2 weeks. At confluence astrocytes were enzymatically detached 
using trypsin–EDTA and plated on glass coverslips (Thermo-Fischer Scientific, Waltham, MA) at a 
density of 20,000-40,000 cells/ml, depending on the experiment. Cultures were incubated at 37 °C, 5% 
CO2, 90% humidity in medium consisting of DMEM (Gibco/Thermo-Fischer Scientific) supplemented 
to reach the final concentration of 5% glutamine, 5% penicillin/streptomycin and 10% Fetal Bovine 
Serum (FBS; Gibco/Thermo-Fischer Scientific). For experiments involving G treatments, cultures were 
incubated at 1 day in vitro (DIV) in a medium containing either 1 or 10 µg/ml of either GR or GO. 
Controls were subjected to the same medium change with the addition of equivalent volumes of the 
respective vehicle (0.09 ppm melamine/H2O for GR flakes, H2O for GO flakes). Cultures were used at 
DIV 2, 4 and 8 (i.e., after 1, 3 and 7 days of GR/GO incubation, respectively). For experiments 
involving astrocyte/neuron co-cultures, astrocytes were seeded on poly-D-lysine-coated (0.01 mg/ml) 
glass coverslips at a density of 40,000 cells/ml, and incubated for 72 h of incubation with GR, GO or 
vehicle. After incubation, non-internalized flakes were removed by two washes. Subsequently, 
enzymatically dissociated cortical neurons obtained from 18-day rat embryos (E18) were plated on the 
top of astrocytes at a density of 40,000 cells/ml in GO/GR-free Neurobasal (Gibco/Thermo-Fischer 
Scientific) supplemented to reach a final concentration of 5% glutamine, 5% penicillin/streptomycin, 
and 10% B27 (Gibco/Thermo-Fischer Scientific). All chemicals were purchased from Life 
Technologies/Thermo-Fischer Scientific unless stated otherwise. All experiments on co-cultures were 
performed at 10 DIV. 
 
Cell viability assay  
Primary rat astrocytes were exposed to GR or GO (10 µg/ml), or to equivalent volumes of the 
respective vehicle (0.09 ppm melamine/H2O for GR flakes, H2O for GO flakes) for 24 h, 72 h and 7 
days. The medium was collected in flow-tubes and cells were detached by trypsin EDTA 0.25% 
(Gibco/Thermo-Fischer Scientific) and re-suspended in 500 ml in PBS in the same flow-tubes of the 
medium. Cells were stained with propidium iodide (PI, 1 µM) for apoptosis quantification. Cells were 
incubated at room temperature (RT) for 15 min in the dark. Cells incubated for 8 h with staurosporin (1 
µM; Sigma Aldrich) were used as positive control for cell death (not shown). Cell death assays were 
performed by flow cytometry analysis using a BD Facs Aria II Cell Sorter (Becton Dickinson, NJ, 
USA). 
 
Immunofluorescence staining 
Primary astrocytes were fixed in phosphate-buffered saline (PBS)/4% paraformaldehyde (PFA) for 20 
min at RT. Cells were permeabilized with 1% Triton X-100 for 5 min, blocked with 2% fetal bovine 
serum (FBS) in PBS/0.05% Tween80 for 30 min at RT and incubated with primary antibodies in the 
same buffer for 45 min. The primary antibodies used were: mouse monoclonal anti-early endosomes 
(EEA1, #610457, BD), rabbit polyclonal anti-lysosomes (LAMP1, #L1418, Sigma-Aldrich), mouse 
monoclonal anti-glial fibrillary acidic protein (GFAP, #G3893, Sigma-Aldrich), guinea pig polyclonal 
anti-vesicular glutamate transporter-1 (VGLUT1, #AB5905, Millipore), rabbit polyclonal anti-vesicular 
GABA transporter (VGAT, #131003, Synaptic System), rabbit polyclonal anti-microtubule-associated 
protein 1A/1B-light chain 3 (LC3, #2775, Cell Signaling Technology), rabbit polyclonal anti-astrocyte 
potassium channel KIR4.1 (KIR4.1, #APC-035, Alomone), rabbit polyclonal anti-NG2 (NG2, 
#AB129051, Abcam), rabbit polyclonal anti-glutamate transporter 1 (EAAT2 – GLT1, #3838, Cell 
Signaling) and rabbit polyclonal anti-glutamate-aspartate transporter (EAAT1 - GLAST, #AB416, 
Abcam). For the last two stainings, cells were not permeabilized with Triton X-100 to visualize only 
the membrane-exposed transporters. After the incubation with primary antibodies and several PBS 
washes, neurons were incubated for 45 min with the secondary antibodies in blocking buffer solution. 
Fluorescently conjugated secondary antibodies were from Molecular Probes (Thermo-Fisher Scientific; 
Alexa Fluor 488 #A11029, Alexa Fluor 568 #A11036, Alexa Fluor 647 #A21450). Samples were 
mounted in ProLong Gold antifade reagent with DAPI (#P36935, Thermo-Fisher Scientific) on 1.5 
mm-thick coverslips. For EEA1, LAMP1, VGLUT1/VGAT-positive terminals and LC3 vesicles, 
image acquisitions were performed using a confocal microscope (SP8, Leica Microsystems GmbH, 
Wetzlar, Germany) at 63x (1.4 NA) magnification. Z-stacks were acquired every 300 nm; 10 
fields/sample (n = 2 coverslips/sample, from 3 independent culture preparations). Offline analysis was 
performed using the ImageJ software and the JACoP plugin for co-localization studies. For each set of 
experiments, all images were acquired using identical exposure settings. For VGLUT and VGAT 
experiments, values were normalized to the relative cell volume calculated on the basis of β-tubulin III 
labeling.  
 
Scanning and Transmission Electron Microscopy 
For SEM analysis, primary astrocytes treated with GR/GO or with the respective vehicle for 72 h were 
fixed with 1.5% glutaraldehyde in 66 mM sodium cacodylate buffer and post-fixed in 1% OsO4. 
Sample dehydration was performed by 5 min washes in 30%, 50%, 70%, 80%, 90%, 96% and 100% 
EtOH solutions. To fully dry the samples, overnight incubation with 99% hexamethyldisilazane 
(HMDS) reagent (#440191, Sigma-Aldrich) was performed. Before SEM acquisition, coverslips were 
sputter-coated with a 10 nm layer of 99% gold (Au) nanoparticles in an Ar-filled chamber 
(Cressington, Sputter Coater 208HR) and imaged using a JEOL JSM-6490LA scanning electron 
microscope. For TEM analysis, astrocytes treated with GR/GO or with the respective vehicle for 1, 3 
and 7 days were fixed with 1.2% glutaraldehyde in 66 mM sodium cacodylate buffer, post-fixed in 1% 
OsO4, 1.5% K4Fe(CN)6, 0.1 M sodium cacodylate, en bloc stained with 1% uranyl acetate, dehydrated 
and flat embedded in epoxy resin (Epon 812, TAAB). After baking for 48 h at 60 °C, the glass 
coverslip was removed from the Epon block by thermal shock using liquid N2. Astrocytes were 
identified by means of a stereomicroscope, excised from the block and mounted on a cured Epon block 
for sectioning using an EM UC6 ultramicrotome (Leica Microsystem, Wetzlar, Germany). Ultrathin 
sections (70 nm thick) were collected on copper mesh grids and observed with a JEM-1011 electron 
microscope operating at 100 kV and equipped with an ORIUS SC1000 CCD camera (Gatan Inc., 
Pleasanton, CA). For each experimental condition, at least 6 images were acquired at a magnification 
up to 10,000x. 
 
Patch-clamp Electrophysiology 
Astrocytes exposed for 72 h to GR and GO (1 and 10 µg/ml) or to the respective vehicle were used for 
patch-clamp recordings. The experiments were performed using an EPC-10 amplifier controlled by 
PatchMaster software (HEKA Elektronik, Lambrecht/Pfalz, Germany) and an inverted DMI6000 
microscope (Leica Microsystems GmbH, Wetzlar, Germany). Patch electrodes fabricated from thick 
borosilicate glasses were pulled to a final resistance of 4−5 MΩ. Recordings with leak current > 100 
pA were discarded. All recordings were acquired at 50 kHz. The standard bath saline contained (in 
mM): 140 NaCl, 4 KCl, 2 MgCl2, 2 CaCl2, 10 HEPES, 5 glucose, pH 7.4, with NaOH and adjusted to 
315 mOsm/l with mannitol. The intracellular (pipette) solution was composed of (in mM): 144 KCl, 2 
MgCl2, 5 EGTA, 10 HEPES, pH 7.2 with KOH;  300 mOsm/l. Experiments were carried out at RT (20–
24°C). All reagents were purchased from Sigma Aldrich. For blocking endocytosis, cells were treated 
with 1 μg/ml NaN3 (Sigma-Aldrich) for 72 h with GO/GR added 1 h after the start of the NaN3 
treatment. 
For co-culture experiments, primary rat cortical neurons were seeded on top of astrocytes that 
had been previously exposed to GR/GO flakes (10 μg/mL) or to the respective vehicle for 72 h, and 
washed twice in GR/GO-free cell medium. Primary neurons were recorded by patch-clamp 
experiments after 10 DIV. Recordings of evoked firing activity in current-clamp configuration were 
performed in Tyrode’s extracellular solution in which D-(−)-2-amino-5-phosphonopentanoic acid 
(AP5, 50 μM), 6-cyano-7 nitroquinoxaline-2,3-dione (CNQX, 10 μM), bicuculline methiodide (BIC, 
30 μM), and (2S)-3-[[(1S)-1-(3,4-Dichlorophenyl)ethyl]amino-2-hydroxypropyl](phenylmethyl) 
phosphinic acid hydrochloride (CGP, 5 μM) were added to block NMDA, non-NMDA, GABAA, and 
GABAB receptors, respectively. The internal solution was composed of (in mM): 126 K gluconate, 4 
NaCl, 1 MgSO4, 0.02 CaCl2, 0.1 BAPTA, 15 glucose, 5 Hepes, 3 ATP, and 0.1 GTP, pH 7.3. Current-
clamp recordings were performed at a holding potential of −70 mV, and action potential firing was 
induced by injecting current steps of 10 pA lasting 500 ms. All parameters were analyzed using the 
Fitmaster (HEKA Elektronik,) and Prism6 (GraphPad Software, Inc.) software. Miniature excitatory 
postsynaptic currents (mEPSCs) and miniature inhibitory postsynaptic currents (mIPSCs) were 
recorded in voltage-clamp configuration in the presence of tetrodotoxin (TTX, 300 nM) to block the 
generation and propagation of spontaneous action potentials. To isolate mEPSC currents, 50 µM D-
AP5 and 30 µM BIC were added to the extracellular solution to block NMDA and GABAA receptors, 
respectively, in the presence of the internal solution (K-gluconate) described above. To isolate mIPSC 
currents, 10 μM CNQX and 10 µM CGP were added to the extracellular solution to block non-NMDA 
and GABAB receptors, respectively, in presence of an internal solution composed of (in mM): 120 
KGluconate, 4 NaCl, 20 KCl, 1 MgSO4, 0.1 EGTA, 15 Glucose, 5 HEPES, 3 ATP, 0.1 GTP (pH 7.2 
with KOH). mPSCs were acquired at 10 kHz sample frequency, filtered at half the acquisition rate with 
an 8-pole low-pass Bessel filter, and analyzed by using the Minianalysis program (Synaptosoft, Leonia, 
NJ, USA). The amplitude, frequency, rise and decay times of mPSCs were calculated using a peak 
detector. All reagents were purchased from Sigma Aldrich or Tocris (Tocris, Avonmouth, Bristol, UK). 
 
Protein Extraction and Western Blotting Analysis 
Total protein lysates were obtained from cells lysed in RIPA buffer (10 mM Tris-HCl, 1 mM EDTA, 
0.5 mM EGTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 140 mM 
NaCl) containing protease and phosphatase inhibitor cocktails (Roche, Monza, Italy). The soluble 
fraction was collected and protein concentration was determined using the BCA Protein Assay Kit 
(Thermo-Fischer Scientific). For western blotting, protein lysates were denatured at 99 °C in 5X 
sample buffer (62.5 mM Tris-HCL, pH 6.8, 2% SDS, 25% glycerol, 0.05% bromophenol blue, 5% β-
mercaptoethanol, deionized water) and separated on SDS-polyacrylamide gels (SDS-PAGE). The 
following antibodies were used: mouse monoclonal anti-LC3 (0231, Nanotools, Teningen, Germany), 
rabbit polyclonal anti-astrocyte potassium channel Kir4.1 (Kir4.1, #APC-035, Alomone), rabbit 
polyclonal anti-glutamate transporter 1 (EAAT2 – GLT1, #3838, Cell Signaling), rabbit polyclonal 
anti-glutamate-aspartate transporter (EAAT1 - GLAST, #AB416, Abcam). Signal intensities were 
quantified using the ChemiDoc MP Imaging System (Biorad, Hercules, CA, USA). For NaN3 
experiments, cells were treated with 1 μg/ml NaN3 (Sigma-Aldrich) before incubation with GO/GR. 
 
Glutamate uptake assay 
For glutamate uptake experiments, astrocytes were plated at concentration of 1 x 105 cell/ml in 6-
well plates. Astrocyte cultures were washed three times with pre-warmed (37 °C) HEPES-buffered 
Hanks' balanced salt solution. 1 µCi/ml of l-[2.3-3H]glutamate (NET490001MC, Perkin Elmer, 
Milan, Italy) was added to unlabeled l-glutamate (#G8415, Sigma) to reach a final concentration of 
50 µM to isolate Na+-dependent transport in standard bath saline contained (in mM): 140 NaCl, 4 KCl, 
2 MgCl2, 2 CaCl2, 10 HEPES, 5 glucose. To isolate Na+-independent transport, NaCl was replaced by 
choline chloride (#C7017, Sigma). To isolate Kir4.1-mediated glutamate uptake, 100 µM Ba2+ 
(#342920, Sigma) was added to the Na+ solution. To block glutamate transporters 100 µM TBOA 
(#2532, Tocris) was added to the Na+ solution. Cultures were incubated with the isotope on a heating 
plate at 37 °C for 10 min. After three washes with PBS, cells were harvested into 400 ml of 1 M 
NaOH solution in H2O. The samples for radioactivity detection were transferred to vials containing 
2 ml of aqueous scintillation mixture and counted using a liquid scintillation counter (1450 LSC 
& Luminescence Counter, MicroBete TriLux, Perkin Elmer). 
 
Statistical Analysis 
The normal distribution of experimental data was assessed using the Kolmogorov-Smirnov test. Data 
were analyzed using the Student’s t-test/Mann-Whitney's U-test or, in case of more than 2 experimental 
groups, by one-way analysis of variance (ANOVA) followed by the Bonferroni's test. 
